Mochida Pharmaceutical Co (FRA:MFY) Cash Flow for Dividends: €0.0 Mil (TTM As of Mar. 2026)


FRA:MFY Mochida Pharmaceutical Co Ltd FRA:MFY
71 GF Score
Price €16.70
GF Value €19.68
! 4 Warning Signs
View Full Analysis

What is Mochida Pharmaceutical Co Cash Flow for Dividends?

Mochida Pharmaceutical Co FRA:MFY 71 Cash Flow for Dividends is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:MFY with a GF Score™ of 71/100 and a GF Value™ of €19.68. The stock has 4 warning signs investors should review.

Mochida Pharmaceutical Co's cash flow for dividends for the three months ended in Mar. 2026 was €0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was €0.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Mochida Pharmaceutical Co's annual payment of dividends declined from Mar. 2024 (€-17.7 Mil) to Mar. 2025 (€-17.6 Mil) and declined from Mar. 2025 (€-17.6 Mil) to Mar. 2026 (€-15.5 Mil).

Mochida Pharmaceutical Co Cash Flow for Dividends Related Terms

Mochida Pharmaceutical Co Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Mochida Pharmaceutical Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mochida Pharmaceutical Co Cash Flow for Dividends Chart

Mochida Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.38 -23.56 -17.73 -17.59 -15.45

Mochida Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:MFY
71GF Score
Mochida Pharmaceutical Co Ltd FRA:MFY
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mochida Pharmaceutical Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of €0.0 Mil mean?
Mochida Pharmaceutical Co (FRA:MFY) has a Cash Flow for Dividends of €0.0 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Mochida Pharmaceutical Co and its competitors.
Is Mochida Pharmaceutical Co's Cash Flow for Dividends too high?
Mochida Pharmaceutical Co's current Cash Flow for Dividends is €0.0 Mil. Overall, Mochida Pharmaceutical Co has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does Mochida Pharmaceutical Co's Cash Flow for Dividends compare to ZTS and UTHR?
Mochida Pharmaceutical Co's Cash Flow for Dividends of €0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Mochida Pharmaceutical Co and its competitors. Mochida Pharmaceutical Co's current Cash Flow for Dividends is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mochida Pharmaceutical Co stock overvalued right now?
Mochida Pharmaceutical Co (FRA:MFY) has a current Cash Flow for Dividends of €0.0 Mil. The stock's GF Value™ is €19.68, compared to a current price of €16.70 — trading 15.1% below its estimated fair value. The current Cash Flow for Dividends is €0.0 Mil. Mochida Pharmaceutical Co's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Mochida Pharmaceutical Co (FRA:MFY), the current Cash Flow for Dividends is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mochida Pharmaceutical Co (FRA:MFY) Overvalued in 2026?

Based on GuruFocus' analysis, Mochida Pharmaceutical Co stock appears to be undervalued. The current stock price of €16.70 is trading 15.1% below its estimated GF Value™ of €19.68.

Key valuation signals for FRA:MFY:

  • Cash Flow for Dividends: €0.0 Mil
  • GF Value™: €19.68 vs. price of €16.70 (15.1% below fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the FRA:MFY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mochida Pharmaceutical Co Business Description

Other Exchanges 4534:Japan
Address 1-1 Ichigayahonmuracho, Shinjuku-ku, Tokyo, JPN, 162-0845
Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.
71GF Score

Get the complete analysis for FRA:MFY

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€16.70
Price
€19.68
GF Value